Last reviewed · How we verify
NCT06008639
Efficacy and Safety of Near Infrared Light Therapy for Alzheimer's Disease
NA trial testing treatment group-Device: NirsCure - Active NirsCure - Active settings in Mild to Moderate Alzheimer's Disease in 80 participants. Status unknown.
31 December 2024
Quick facts
| Lead sponsor | Danyang Huichuang Medical Equipment Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 March 2023 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 2 locations across China |
Drugs / interventions tested
- treatment group-Device: NirsCure - Active NirsCure - Active settings
- placebo group-Device: NirsCure - Sham NirsCure - Sham settings
Conditions studied
- Mild to Moderate Alzheimer's Disease — all drugs for Mild to Moderate Alzheimer's Disease →
Sponsor
Danyang Huichuang Medical Equipment Co., Ltd.
Who can join
50 and older, any sex, with Mild to Moderate Alzheimer's Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To explore the efficacy and safety of near infrared light therapy for Alzheimer's disease. Each subject will be numbered and their medical records will be established. The subjects will be randomly assigned to the treatment group or the control group for 30 minutes/day (5-6 days a week) for 4 months while the treatment group is active settings and the control group is sham settings.Follow-up visits will be conducted at 2 months, 4 months and 2 months after treatment. At each follow-up, scale assessment, blood, MRI, and EEG were observed
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06008639
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Danyang Huichuang Medical Equipment Co., Ltd. trials
Trials by the same sponsor.
- NCT07262645 — Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A) · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06008639 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Danyang Huichuang Medical Equipment Co., Ltd.
- Last refreshed: 6 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06008639.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing